LexDanaLexDanabeta
Inventor

Graziella I. Shevlin

Inventor
San Diego, CA, US

Overview

14→
Patents
2001–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 14 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes24%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium16%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry4%
PatentTitleYear
10,683,298Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors202010,167,290Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors20199,771,371'Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors'20179,193,692'Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors'20159,079,900'Methods of synthesis and purification of heteroaryl compounds'20158,907,087'Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors'20148,569,494'Methods of synthesis and purification of heteroaryl compounds'20138,507,492'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway'20138,492,381'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway'20138,372,976'Methods of treatment comprising the administration of heteroaryl compounds'20138,110,578'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway'20127,981,893'Heteroaryl compounds, compositions thereof, and methods of treatment therewith'20116,372,739'Compounds and methods for modulation of estrogen receptors'20026,291,456'Compounds and methods for modulation of estrogen receptors'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2013Based in San Diego, CA, US· patent location history
2011–2020Patents assigned to SIGNAL PHARM LLC (12)· patent assignee history
2012–2013Patents assigned to PERRIN-NINKOVIC SOPHIE (5)· patent assignee history
2012–2013Patents assigned to ELSNER JAN (4)· patent assignee history
2012–2013Patents assigned to HARRIS ROY L (4)· patent assignee history
2012–2013Patents assigned to MORTENSEN DEBORAH (4)· patent assignee history
2014–2020Based in Lima, PE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SIGNAL PHARM LLC122011–2020
PERRIN-NINKOVIC SOPHIE52012–2013
ELSNER JAN42012–2013
HARRIS ROY L42012–2013
MORTENSEN DEBORAH42012–2013
Locations
LocationPatentsSpan
San Diego, California, US82001–2013
Lima, PE62014–2020